HIV Diagnostics Market projected to grow with significant CAGR over the forecast period

HIV Diagnostics Market: Acquired immune deficiency syndrome (AIDS) is a retroviral infectious disease caused by human immunodeficiency virus (HIV). HIV attacks body immune system ideally CD4 cells (T cells), which helps the immune system to fight infections. HIV spreads through body fluids such as blood donation non-sterile needles, sharing needles with someone who is HIV infected, and sexual interactions. The HIV diagnosis is done by viral load test, saliva test, and blood test. Most accurate test results can be obtained by enzyme-linked immunosorbent assay (ELISA) test initial stages and western blot method on later stages. Currently, there was no effective cure exists for HIV, but with proper medical care, it can be controlled.

HIV diagnostics market is increasing globally due to rise in prevalence of HIV/AIDS, a rise in the number of blood transfusions and blood donations, benefits of point-of-care instruments & kits in which patients can be diagnosed even outside the laboratory setting, and increasing government initiatives. In addition, technological advancements in disease diagnostic tests, improvement and commercialization of novel, the regulatory approved point of care and rapid CD4, p24 antigen and EID tests are expected to boost the HIV diagnostics market. But, lack of awareness in many undeveloped countries, strict government regulations and unfavorable reimbursement policies would limit the growth of the market.

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-hiv-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

HIV Diagnostics Market is categorized on the basis of test and end users.

1. Type of test

• CD4 Count
• Antibody Test
• Viral Identification
• Viral Load
• Others

2. End-users

Hospitals, diagnostic centers, blood Banks and home Care Settings.

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-hiv-diagnostics-market/#ulp-c654SbFYO64MsOhu

And lastly, geographically HIV diagnostics market has been divided into following regions-North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominate HIV diagnostics market due to a rapid adoption of technologically, advanced diagnostic solutions, and growing demand for portable and point of care (POC) diagnostic devices. In addition to that, a large pool of patients suffering from HIV and mandatory implementation of HIV screening tests are expected to boost regional penetration of HIV diagnostics. Asia-Pacific expected to be a lucrative market for HIV diagnostics, owing to growing patients suffering from HIV/AIDS and increase in awareness among the population related to HIV diagnostics. In the Middle East and Africa region, South Africa has the enormous opportunity due to increasing awareness and presence of a large number of infected people. Some of the key players in HIV diagnostics market are F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Siemens Healthineers) (Germany), Merck KGaA (Germany) Hologic, Inc. (U.S.), Fisher Bioblock Holding II SNC (Thermo-Fisher Scientific) (U.S.),Becton, Dickinson and Company (U.S.),Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.) to name a few. In 2015, BioLytical Laboratories Inc., a leading manufacturer of point-of-care rapid diagnostic tests, received USFDA approval for its INSTI HIV Antibody Test for use in detecting antibodies to type-2 HIV.

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-hiv-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

Global HIV diagnosis market is growing steadily. Government and non-government organizations are also participating in creating and growing awareness related to early HIV diagnosis and available diagnostic tests and equipment. The unmet requirements in Asia and Africa region for HIV diagnosis and the government initiatives taken in the region will help boost the market for HIV diagnostics. Market players adopting mergers and acquisitions to increase the market position in HIV diagnostics market. In addition, the market has a number of pipeline products for the accurate and quick diagnosis of HIV few of them are Visitect CD4, Chipcare CD4, and MBIO CD4. Antibody diagnosis test is predominant among the segments. Due to the introduction of point of care products can easily and quickly diagnose disease.

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-hiv-diagnostics-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

Website @ https://www.precisionbusinessinsights.com